Walgreens Boots Alliance Management
Management criteria checks 1/4
Walgreens Boots Alliance's CEO is Tim Wentworth, appointed in Oct 2023, has a tenure of 1.08 years. directly owns 0.019% of the company’s shares, worth $1.34M. The average tenure of the management team and the board of directors is 1.3 years and 3.1 years respectively.
Key information
Tim Wentworth
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 1.1yrs |
| CEO ownership | 0.02% |
| Management average tenure | 1.3yrs |
| Board average tenure | 3.1yrs |
Recent management updates
Recent updates
Walgreens: 11.9% Dividend Yield Still On Unsteady Legs
Nov 18Walgreens Q4: 2 Signs Of A Dividend Trap
Oct 29Walgreens: Undervalued Pharma Giant Poised For A Turnaround Amid Cost-Cutting And Activist Investor Potential
Oct 23Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Just Reported Yearly Earnings: Have Analysts Changed Their Mind On The Stock?
Oct 17
Walgreens: A Turnaround Stock To Avoid
Oct 15Walgreens Stock: Cheap At 3x FWD P/E, But Still Not Worth Buying
Sep 29Is Walgreens Boots Alliance (NASDAQ:WBA) A Risky Investment?
Sep 09Walgreens: Short Interest Surge Indicates It's Time To Cut Your Losses
Sep 06Is Walgreens Ready To Rebound?
Aug 23Walgreens Boots Alliance: Likely A Value Trap, But Could Be A Speculative Long-Term Play
Aug 13Walgreens: A Painful Turnaround Lesson
Aug 02Walgreens: Here's What Comes Next
Jul 09Walgreens: Yielding Over 8% Following The Earnings Drop
Jul 02Walgreens: Beware The Value Trap Ahead Of Earnings
Jun 24Walgreens: Another Dividend Cut Could Be Coming Soon (Rating Downgrade)
May 305 Reasons Walgreens Fell By 6.4% To Nearly 25-Year Lows
May 22Walgreens: Hold Tight, Let It Turn Around First
May 06Walgreens Boots Alliance (NASDAQ:WBA) Use Of Debt Could Be Considered Risky
May 053 Reasons Walgreens Can See Upside (Rating Upgrade)
Apr 10Investors Still Waiting For A Pull Back In Walgreens Boots Alliance, Inc. (NASDAQ:WBA)
Apr 08Walgreens: New Management Team And Cost-Plus Model Are Exactly What The Doctor Prescribed
Apr 04Walgreens Earnings Preview: Revenue Estimates Holding Up; It's A Cost Structure Problem
Mar 27Walgreens' Strategic Pivot
Mar 21Walgreens Q2, Dow Exit, And Bet Against Wall Street
Mar 15Walgreens: New CEO Looking To Right The Ship
Feb 13Walgreens Boots Alliance (NASDAQ:WBA) Use Of Debt Could Be Considered Risky
Jan 19Walgreens Boots Alliance: Income Opportunity After Dividend Cut
Jan 17Walgreens Q1: Dividend Cut Now What? (Rating Upgrade)
Jan 10After Leaping 26% Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Are Not Flying Under The Radar
Dec 24Walgreens Boots Alliance's (NASDAQ:WBA) Dividend Will Be $0.48
Oct 31Walgreens Boots Alliance (NASDAQ:WBA) Has A Somewhat Strained Balance Sheet
Oct 02CEO
Tim Wentworth (64 yo)
1.1yrs
Tenure
Mr. Timothy C. Wentworth, also known as Tim, served as Director of Ushur, Inc. since February 2022. He served as the Chief Executive Officer of Evernorth at Evernorth Health, Inc. (formerly known as Expres...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman of the Board | 12.6yrs | US$7.57m | 0.096% $ 6.9m | |
| Executive VP & Global CFO | 1.3yrs | US$1.83m | 0.048% $ 3.4m | |
| Chief Operating Officer of International | no data | US$5.43m | 0.25% $ 17.9m | |
| CEO & Director | 1.1yrs | no data | 0.019% $ 1.3m | |
| Senior VP | 1.3yrs | no data | 0.0019% $ 137.6k | |
| Executive VP & Chief Information Officer | less than a year | no data | 0.0066% $ 471.6k | |
| Vice President of Global Investor Relations | no data | no data | no data | |
| Senior VP and Global Chief Compliance & Ethics Officer | no data | no data | no data | |
| Executive VP & Global Chief Legal Officer | less than a year | no data | no data | |
| Executive VP & Chief Human Resources Officer | no data | no data | no data | |
| Head of M&A - Asia | no data | no data | no data | |
| Executive VP | 3yrs | no data | 0.0087% $ 622.2k |
1.3yrs
Average Tenure
53.5yo
Average Age
Experienced Management: WBA's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman of the Board | 12.6yrs | US$7.57m | 0.096% $ 6.9m | |
| CEO & Director | 1.1yrs | no data | 0.019% $ 1.3m | |
| Lead Independent Director | 14.6yrs | US$366.85k | 0.00025% $ 17.9k | |
| Independent Director | 4.1yrs | US$300.00k | 0.00052% $ 37.3k | |
| Independent Director | 18.1yrs | US$319.97k | 0.0024% $ 175.6k | |
| Independent Director | 9.6yrs | US$315.00k | 0.0058% $ 414.3k | |
| Independent Director | 2.1yrs | US$84.62k | 0.0036% $ 255.9k | |
| Independent Director | 12.6yrs | US$325.00k | 0.00014% $ 10.0k | |
| Director | less than a year | no data | 0.00041% $ 29.4k | |
| Independent Director | 2.2yrs | US$115.29k | 0.00035% $ 25.1k | |
| Director | 1.3yrs | US$14.13k | 0.0019% $ 136.9k | |
| Independent Director | less than a year | no data | no data |
3.1yrs
Average Tenure
65yo
Average Age
Experienced Board: WBA's board of directors are considered experienced (3.1 years average tenure).